Mechanism of Action of Eltrombopag
Introduction Eltrombopag is an oral thrombopoietin receptor agonist used to increase platelet production in selected patients with thrombocytopenia. It is marketed under the brand name Promacta in the United States and Revolade in some other countries. Pharmacologically, eltrombopag is classified as a non-peptide thrombopoietin receptor agonist. Thrombopoietin, also called TPO, is the natural hormone that … Read more
